The global market for Pneumonia Testing was estimated at US$1.2 Billion in 2023, and is projected to reach US$1.8 Billion by 2030, growing at a CAGR of 6.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Global Pneumonia Testing Market]( "Global Pneumonia Testing Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Immunodiagnostics Method segment, which is expected to reach US$339.9 Million by 2030 with a CAGR of a 5.4%. The Molecular Diagnostics Method segment is also set to grow at 5.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $312.2 Million in 2023, and China, forecasted to grow at an impressive 10.1% CAGR to reach $396.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Pneumonia Testing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pneumonia Testing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Pneumonia Testing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, AdvanDx, Inc., Beckman Coulter, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 19 Featured):
- Abbott Laboratories
- AdvanDx, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Cepheid, Inc.
- concile GmbH
- Diamedix Corporation
- DiaSorin SpA
- F. Hoffmann-La Roche AG
- Fast Track Diagnostics Luxembourg S.a.r.l.
- Hologic, Inc.
- Meridian Bioscience, Inc.
- Quest Diagnostics, Inc.
- Quidel Corporation
- Seracare Life Sciences, Inc.
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Pneumonia Testing: Overview & Outlook
- Pneumonia Testing - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
3. MARKET TRENDS & DRIVERS
- Concerns Over Childhood Pneumonia Increase the Need for Testing
- Rising Cases of Community-Acquired Pneumonia: Major Driver
- Increased Incidence of Hospital Acquired Pneumonia Favors Growth
- Prevalence of Bacterial Pneumonia Augurs Well
- Growing Cases of Aspiration Pneumonia Add to Demand
- POC Testing Gains Traction
- Increased Adoption of Molecular Diagnosis
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Pneumonia Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Pneumonia Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Pneumonia Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Point of Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Point of Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Point of Care Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 20: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 21: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 25: World Pneumonia Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: USA Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: USA 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 29: USA Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: USA Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: USA 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
- Table 32: Canada Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Canada Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Canada 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 35: Canada Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: Canada Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: Canada 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 38: Japan Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 39: Japan Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: Japan 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 41: Japan Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: Japan Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: Japan 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 44: China Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: China Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: China 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 47: China Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 48: China Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: China 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 50: Europe Recent Past, Current & Future Analysis for Pneumonia Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 51: Europe Historic Review for Pneumonia Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Europe 16-Year Perspective for Pneumonia Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: Europe Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: Europe 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: Europe Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: Europe 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 59: France Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: France Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: France 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 62: France Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: France Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: France 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 65: Germany Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 66: Germany Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Germany 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Germany Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Germany 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
- Table 71: Italy Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 72: Italy Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 73: Italy 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 75: Italy Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 76: Italy 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 77: UK Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 78: UK Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 79: UK 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 81: UK Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 82: UK 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
- Table 83: Spain Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 84: Spain Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 85: Spain 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 86: Spain Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 87: Spain Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 88: Spain 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
- Table 89: Russia Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 90: Russia Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 91: Russia 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 92: Russia Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 93: Russia Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 94: Russia 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 98: Rest of Europe Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 99: Rest of Europe Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 100: Rest of Europe 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Pneumonia Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Pneumonia Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Pneumonia Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 105: Asia-Pacific Historic Review for Pneumonia Testing by Method - Immunodiagnostics, Molecular Diagnostics and Point of Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 106: Asia-Pacific 16-Year Perspective for Pneumonia Testing by Method - Percentage Breakdown of Value Sales for Immunodiagnostics, Molecular Diagnostics and Point of Care Testing for the Years 2014, 2024 & 2030
- Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 108: Asia-Pacific Historic Review for Pneumonia Testing by End-Use - Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 109: Asia-Pacific 16-Year Perspective for Pneumonia Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
LATIN AMERICA
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Pneumonia Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned
- Abbott Laboratories
- AdvanDx, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Cepheid, Inc.
- concile GmbH
- Diamedix Corporation
- DiaSorin SpA
- F. Hoffmann-La Roche AG
- Fast Track Diagnostics Luxembourg S.a.r.l.
- Hologic, Inc.
- Meridian Bioscience, Inc.
- Quest Diagnostics, Inc.
- Quidel Corporation
- Seracare Life Sciences, Inc.
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 259 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.2 Billion |
| Forecasted Market Value ( USD | $ 1.8 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
